NGL: Test, Opiates, Over The Counter

Product code NGL, “Test, Opiates, Over The Counter” in FDA's classification database, is a Class II device type under 21 CFR 862.3650 (opiate test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 23 clearances under NGL, 21 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
NGL
Regulation
21 CFR 862.3650
Class
II
Panel
Clinical Toxicology
Clearances
23
Most recent
Dec 23, 2025
Median review, last 2 years
49 days
Third-party review
Eligible
Implant
No

What it covers

An opiate test system is a device intended to measure any of the addictive narcotic pain-relieving opiate drugs in blood, serum, urine, gastric contents, and saliva. An opiate is any natural or synthetic drug that has morphine-like pharmocological actions. The opiates include drugs such as morphine, morphine glucoronide, heroin, codeine, nalorphine, and meperedine. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose and in monitoring the levels of opiate administration to ensure appropriate therapy.

The identification in 21 CFR 862.3650, opiate test system. FDA gives NGL no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K253567Healgen Accurate Urine Drug Screen Dip Card; Healgen Accurate Home Urine Drug Test Dip CardHealgen Scientific,, LLCDec 23, 2025Traditional
K250803Deepblue Multi-Drug Urine Test Cup; Deepblue Home Muti-Drug Urine Test CupAnhui Deepblue Medical Technological Co., Ltd.Apr 15, 2025Traditional
K250067Dochek® Multi-Drug Urine Test Cup; Dochek® Multi-Drug Urine Test Cup ProGuangzhou Decheng Biotechnology Co., Ltd.Feb 20, 2025Traditional
K242428Dochek® Fentanyl Urine Test Strip, Dochek® Fentanyl Urine Test Strip Plus, Dochek® Fentanyl Urine Test Card, Dochek® Fentanyl Urine Test Card Plus, Dochek® Fentanyl Urine Test Cup and Dochek® Fentanyl Urine Test Cup PlusGuangzhou Decheng Biotechnology Co., Ltd.Feb 6, 2025Traditional
K243365Healgen Accurate Muti-Drug Urine Drug Screen Cup; Healgen Accurate Home Muti-Drug Urine Test CupHealgen Scientific,, LLCDec 17, 2024Traditional
K243064ETERBIO Fentanyl/Norfentanyl Rapid Test (Colloidal Gold); ETERBIO Fentanyl/Norfentanyl Home TestEterbio, Inc.Nov 20, 2024Traditional
K242802CLUNGENE Fentanyl Home Test Cassette; CLUNGENE Fentanyl Test CassetteHangzhou Clongene Biotech Co., Ltd.Nov 8, 2024Traditional
K241869BioSieve™ Fentanyl FIA Home Test Kit; BioSieve™ Fentanyl FIA Pro Test Kit; BioSieve™ Toxismart ReaderVivachek Biotech (Hangzhou) Co., Ltd.Oct 4, 2024Traditional
K241969Hightop® Home Use Fentanyl/Norfentanyl Urine Rapid Test Panel; Hightop® Fentanyl/Norfentanyl Urine Rapid Test PanelQingdao Hightop Biotech Co., Ltd.Aug 14, 2024Traditional
K241741SAFElife™ Fentanyl Urine Home Test (Cassette); SAFElife™ Fentanyl (FTY) Urine Test Cassette; SAFElife™ T-Dip Fentanyl Urine Home Test (Dip Card); SAFElife™ T-Dip Fentanyl (FTY) Urine Test PanelGuangzhou Wondfo Biotech Co., Ltd.Jul 16, 2024Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 23 with a free account)

Clearances by year

21 NGL 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2025439
20241340
2023116
2020146
2019128
2018121

Who submits

15 applicants cleared a NGL device since 2011. 67% of the clearances went to applicants in China, then United States (33%). By type: Traditional 100%.

ApplicantClearances since 2011
Healgen Scientific,, LLC4
Hangzhou Clongene Biotech Co., Ltd.3
Guangzhou Decheng Biotechnology Co., Ltd.2
Allsource Screening Solutions1
Anhui Deepblue Medical Technological Co., Ltd.1
Assure Tech., LLC1
Co-Innovation Biotech Co., Ltd.1
Eterbio, Inc.1

How FDA classifies it

Class II (special controls). An opiate test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.

From 21 CFR 862.3650. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 862.3650 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NGL clearances declared.

Ask about NGL

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about NGL

What is FDA product code NGL?

Product code NGL, “Test, Opiates, Over The Counter” in FDA's classification database, is a Class II device type under 21 CFR 862.3650 (opiate test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 23 clearances under NGL, 21 of them since 2011.

How many 510(k) clearances are there under NGL?

FDA’s 510(k) database listed 23 clearances under NGL as of Oct 29, 2026, 21 of them decided since 2011; the most recent decision was Dec 23, 2025. The Predicate Finder searches the live database.

How long does FDA take to clear a NGL 510(k)?

For the 7 NGL clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 49 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most NGL clearances?

Since 2011: Healgen Scientific,, LLC (4), Hangzhou Clongene Biotech Co., Ltd. (3), Guangzhou Decheng Biotechnology Co., Ltd. (2), Allsource Screening Solutions (1) and Anhui Deepblue Medical Technological Co., Ltd. (1). 15 applicants have cleared a NGL device in that time.

Sources

  1. FDA product classification: NGL · Product Classification database
  2. 21 CFR 862.3650: Opiate test system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for NGL · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow NGLGet an email when FDA clears, recalls or publishes guidance for NGL devices.

Know what FDA already cleared.